This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Gemini Therapeutics Crecimiento futuro
Future controles de criterios 0/6
Información clave
20.9%
Tasa de crecimiento de los beneficios
34.8%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Biotechs | 24.0% |
| Tasa de crecimiento de los ingresos | n/a |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2024 | N/A | -14 | -12 | N/A | 1 |
| 12/31/2023 | N/A | -14 | -12 | N/A | 1 |
| 12/31/2022 | N/A | -14 | -12 | N/A | 1 |
| 9/30/2022 | N/A | -43 | -43 | -43 | N/A |
| 6/30/2022 | N/A | -59 | -55 | -55 | N/A |
| 3/31/2022 | N/A | -68 | -61 | -61 | N/A |
| 12/31/2021 | N/A | -72 | -60 | -60 | N/A |
| 9/30/2021 | N/A | -68 | -56 | -56 | N/A |
| 6/30/2021 | N/A | -60 | -47 | -47 | N/A |
| 3/31/2021 | N/A | -50 | -38 | -38 | N/A |
| 12/31/2020 | N/A | -41 | -33 | -33 | N/A |
| 9/30/2020 | N/A | -36 | -35 | -35 | N/A |
| 6/30/2020 | N/A | -37 | -37 | -37 | N/A |
| 3/31/2020 | N/A | -41 | -39 | -39 | N/A |
| 12/31/2019 | N/A | -41 | -39 | -39 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: GMTX is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: GMTX is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: GMTX is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: Insufficient data to determine if GMTX's revenue is forecast to grow faster than the US market.
Ingresos de alto crecimiento: GMTX is forecast to have no revenue next year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if GMTX's Return on Equity is forecast to be high in 3 years time